Annual revenue:
$560.23M+$125.98M(+29.01%)Summary
- As of today (July 7, 2025), RARE annual revenue is $560.23 million, with the most recent change of +$125.98 million (+29.01%) on December 31, 2024.
- During the last 3 years, RARE annual revenue has risen by +$208.82 million (+59.43%).
- RARE annual revenue is now at all-time high.
Performance
RARE Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$139.29M-$25.59M(-15.52%)Summary
- As of today (July 7, 2025), RARE quarterly revenue is $139.29 million, with the most recent change of -$25.59 million (-15.52%) on March 31, 2025.
- Over the past year, RARE quarterly revenue has increased by +$30.46 million (+27.99%).
- RARE quarterly revenue is now -15.52% below its all-time high of $164.88 million, reached on December 31, 2024.
Performance
RARE Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$590.69M+$30.46M(+5.44%)Summary
- As of today (July 7, 2025), RARE TTM revenue is $590.69 million, with the most recent change of +$30.46 million (+5.44%) on March 31, 2025.
- Over the past year, RARE TTM revenue has increased by +$148.10 million (+33.46%).
- RARE TTM revenue is now at all-time high.
Performance
RARE TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
RARE Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.0% | +28.0% | +33.5% |
| 3 y3 years | +59.4% | +74.3% | +78.0% |
| 5 y5 years | +440.2% | +283.6% | +270.5% |
RARE Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +59.4% | -15.5% | +55.9% | at high | +76.7% |
| 5 y | 5-year | at high | +440.2% | -15.5% | +125.7% | at high | +270.5% |
| alltime | all time | at high | >+9999.0% | -15.5% | >+9999.0% | at high | >+9999.0% |
RARE Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $139.29M(-15.5%) | $590.69M(+5.4%) |
| Dec 2024 | $560.23M(+29.0%) | $164.88M(+18.2%) | $560.23M(+7.2%) |
| Sep 2024 | - | $139.49M(-5.1%) | $522.75M(+8.6%) |
| Jun 2024 | - | $147.03M(+35.1%) | $481.30M(+8.7%) |
| Mar 2024 | - | $108.83M(-14.6%) | $442.59M(+1.9%) |
| Dec 2023 | $434.25M(+19.5%) | $127.39M(+29.9%) | $434.25M(+5.9%) |
| Sep 2023 | - | $98.05M(-9.5%) | $410.20M(+1.8%) |
| Jun 2023 | - | $108.31M(+7.8%) | $402.86M(+4.9%) |
| Mar 2023 | - | $100.50M(-2.8%) | $383.89M(+5.7%) |
| Dec 2022 | $363.33M(+3.4%) | $103.35M(+13.9%) | $363.33M(+5.8%) |
| Sep 2022 | - | $90.70M(+1.5%) | $343.37M(+2.7%) |
| Jun 2022 | - | $89.34M(+11.8%) | $334.31M(+0.7%) |
| Mar 2022 | - | $79.94M(-4.1%) | $331.95M(-5.5%) |
| Dec 2021 | $351.41M(+29.7%) | $83.39M(+2.1%) | $351.41M(-2.3%) |
| Sep 2021 | - | $81.65M(-6.1%) | $359.56M(+0.0%) |
| Jun 2021 | - | $86.97M(-12.5%) | $359.38M(+7.6%) |
| Mar 2021 | - | $99.39M(+8.6%) | $334.12M(+23.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $271.03M(+161.3%) | $91.54M(+12.4%) | $271.03M(+26.0%) |
| Sep 2020 | - | $81.47M(+32.0%) | $215.08M(+34.9%) |
| Jun 2020 | - | $61.71M(+70.0%) | $159.41M(+30.8%) |
| Mar 2020 | - | $36.31M(+2.0%) | $121.85M(+17.5%) |
| Dec 2019 | $103.71M(+101.4%) | $35.59M(+38.0%) | $103.71M(+22.9%) |
| Sep 2019 | - | $25.80M(+6.8%) | $84.38M(+20.0%) |
| Jun 2019 | - | $24.15M(+32.9%) | $70.34M(+19.2%) |
| Mar 2019 | - | $18.17M(+11.8%) | $58.99M(+14.6%) |
| Dec 2018 | $51.49M(+1871.5%) | $16.26M(+38.2%) | $51.49M(+36.8%) |
| Sep 2018 | - | $11.76M(-8.1%) | $37.65M(+44.3%) |
| Jun 2018 | - | $12.79M(+19.8%) | $26.08M(+96.3%) |
| Mar 2018 | - | $10.68M(+342.3%) | $13.29M(+408.8%) |
| Dec 2017 | $2.61M(+1863.9%) | $2.41M(+1119.2%) | $2.61M(+1186.7%) |
| Sep 2017 | - | $198.00K(+3860.0%) | $203.00K(+52.6%) |
| Dec 2016 | $133.00K | $5000.00(-95.5%) | $133.00K(+3.9%) |
| Sep 2016 | - | $111.00K(+552.9%) | $128.00K(+652.9%) |
| Jun 2016 | - | $17.00K | $17.00K |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual revenue?
- What is the all time high annual revenue for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual revenue year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly revenue?
- What is the all time high quarterly revenue for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly revenue year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. TTM revenue?
- What is the all time high TTM revenue for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. TTM revenue year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual revenue?
The current annual revenue of RARE is $560.23M
What is the all time high annual revenue for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual revenue is $560.23M
What is Ultragenyx Pharmaceutical Inc. annual revenue year-on-year change?
Over the past year, RARE annual revenue has changed by +$125.98M (+29.01%)
What is Ultragenyx Pharmaceutical Inc. quarterly revenue?
The current quarterly revenue of RARE is $139.29M
What is the all time high quarterly revenue for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly revenue is $164.88M
What is Ultragenyx Pharmaceutical Inc. quarterly revenue year-on-year change?
Over the past year, RARE quarterly revenue has changed by +$30.46M (+27.99%)
What is Ultragenyx Pharmaceutical Inc. TTM revenue?
The current TTM revenue of RARE is $590.69M
What is the all time high TTM revenue for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high TTM revenue is $590.69M
What is Ultragenyx Pharmaceutical Inc. TTM revenue year-on-year change?
Over the past year, RARE TTM revenue has changed by +$148.10M (+33.46%)